AASS | Aminoadipate-semialdehyde synthase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ACADM | Acyl-CoA dehydrogenase, C-4 to C-12 straight chain | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ACADS | Acyl-CoA dehydrogenase, C-2 to C-3 short chain | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ACADVL | Acyl-CoA dehydrogenase, very long chain | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ACOX1 | Acyl-CoA oxidase 1, palmitoyl | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ADH1A | Alcohol dehydrogenase 1A (class I), alpha polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
ADH1B | Alcohol dehydrogenase 1B (class I), beta polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
ADH1C | Alcohol dehydrogenase 1C (class I), gamma polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
ADH4 | Alcohol dehydrogenase 4 (class II), pi polypeptide | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
ADH7 | Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
ADO | 2-aminoethanethiol (cysteamine) dioxygenase | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
AKR1B1 | Aldo-keto reductase family 1, member B1 (aldose reductase) | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
AKR1D1 | Aldo-keto reductase family 1, member D1 | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
AKR7A2 | Aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ALDH18A1 | Aldehyde dehydrogenase 18 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ALDH1A1 | Aldehyde dehydrogenase 1 family, member A1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ALDH3A1 | Aldehyde dehydrogenase 3 family, member A1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ALDH4A1 | Aldehyde dehydrogenase 4 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ALDH5A1 | Aldehyde dehydrogenase 5 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ALOX12 | Arachidonate 12-lipoxygenase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
AOC3 | Amine oxidase, copper containing 3 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
BBOX1 | Butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
BCKDHA | Branched chain keto acid dehydrogenase E1, alpha polypeptide | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
BDH1 | 3-hydroxybutyrate dehydrogenase, type 1 | Candidate cardiovascular disease genes Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
BDH2 | 3-hydroxybutyrate dehydrogenase, type 2 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
BLVRB | Biliverdin reductase B (flavin reductase (NADPH)) | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CAT | Catalase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CDO1 | Cysteine dioxygenase type 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
CHDH | Choline dehydrogenase | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CP | Ceruloplasmin (ferroxidase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CRYL1 | Crystallin, lambda 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CRYZ | Crystallin, zeta (quinone reductase) | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CYB5R1 | Cytochrome b5 reductase 1 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
CYP11A1 | Cytochrome P450, family 11, subfamily A, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
CYP11B1 | Cytochrome P450, family 11, subfamily B, polypeptide 1 | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enriched |
CYP11B2 | Cytochrome P450, family 11, subfamily B, polypeptide 2 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
CYP17A1 | Cytochrome P450, family 17, subfamily A, polypeptide 1 | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CYP19A1 | Cytochrome P450, family 19, subfamily A, polypeptide 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
CYP1A2 | Cytochrome P450, family 1, subfamily A, polypeptide 2 | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
CYP1B1 | Cytochrome P450, family 1, subfamily B, polypeptide 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
CYP21A2 | Cytochrome P450, family 21, subfamily A, polypeptide 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
CYP24A1 | Cytochrome P450, family 24, subfamily A, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
CYP2A13 | Cytochrome P450, family 2, subfamily A, polypeptide 13 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
CYP2A7 | Cytochrome P450, family 2, subfamily A, polypeptide 7 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
CYP2C19 | Cytochrome P450, family 2, subfamily C, polypeptide 19 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP2C8 | Cytochrome P450, family 2, subfamily C, polypeptide 8 | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CYP2C9 | Cytochrome P450, family 2, subfamily C, polypeptide 9 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
CYP2D6 | Cytochrome P450, family 2, subfamily D, polypeptide 6 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CYP2E1 | Cytochrome P450, family 2, subfamily E, polypeptide 1 | Cancer-related genes Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |